| J01FA09 |
Clarithromycin |
FROMILID |
Granules for oral suspension |
125 mg/ 5 ml - 60 ml |
mg |
1 |
KRKA, d.d., Словения |
500 |
mg |
- |
9.1 |
2.40333 |
7.21 |
25% |
1.8 |
за деца до 8 години |
A38,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42 |
КЦРР-2423/22.02.2013 г.; НСР-2286/13.01.2014.; НСР-7985/08.02.2016. |
02.03.2016 |
08.09.2012 |
|
Заличен |
2400 |
| J01FA09 |
Clarithromycin |
Klacid |
Granules for oral suspension |
250 mg/5 ml - 60 ml |
mg |
1 |
Abbott Laboratories Limited, Обединено Кралство |
500 |
mg |
- |
19.01 |
2.41667 |
14.5 |
25% |
3.63 |
за деца до 8 години |
A38,H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
КЦРР-471/19.04.2012 г.; НСР-2446/21.01.2014 |
16.02.2014 |
08.09.2012 |
|
Заличен |
1185 |
| J01FA09 |
Clarithromycin |
KLACID |
Granules for oral suspension |
125 mg/5 ml - 100 ml |
mg |
1 |
Abbott Laboratories Limited, Обединено Кралство |
500 |
mg |
- |
13.12 |
2.41667 |
12.08 |
25% |
3.02 |
за деца до 8 години |
A38,H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
№ 177/ 21.06.2011; КЦРР-832/15.06.2012 г..; НСР-2447/21.01.2014 |
16.02.2014 |
08.09.2012 |
|
Заличен |
1263 |
| J01FA09 |
Clarithromycin |
Lekoklar |
Granules for oral suspension |
250 mg/5 ml - 60 ml |
mg |
1 |
Sandoz d.d., Словения |
500 |
mg |
- |
14.87 |
2.41667 |
14.5 |
25% |
3.63 |
за деца до 8 години |
A38,H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
КЦРР-1709/27.11.2012 г.; НСР-2242/20.12.2013 |
16.01.2014 |
|
|
Заличен |
1459 |
| J01FA09 |
Clarithromycin |
Lekoklar |
Granules for oral suspension |
125 mg/ 5 ml - 60 ml |
mg |
1 |
Sandoz d.d., Словения |
500 |
mg |
- |
9.48 |
2.41667 |
7.25 |
25% |
1.81 |
за деца до 8 години |
A38,H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
КЦРР-1709/27.11.2012 г.; НСР-2243/20.12.2013 |
16.01.2014 |
|
|
Заличен |
1458 |
| J01FA10 |
Azithromycin |
J01FA10 Azithromycin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01FA10 |
Azithromycin |
Azatril |
Capsule, hard |
250 |
mg |
8 |
Актавис EАД, България |
300 |
mg |
- |
15.07 |
1.396 |
9.31 |
25% |
2.33 |
|
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
КЦРР-2849/20.03.2013 г.; НСР-1775/21.1.2013 |
16.12.2013 |
08.09.2012 |
|
Заличен |
1815 |
| J01FA10 |
Azithromycin |
Azatril |
Capsule, hard |
250 |
mg |
6 |
Актавис EАД, България |
300 |
mg |
- |
9.66 |
1.396 |
6.98 |
25% |
1.75 |
|
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
КЦРР-2463/27.02.2013 г; НСР-1775/21.1.2013 |
16.12.2013 |
08.09.2012 |
|
Заличен |
1691 |
| J01FA10 |
Azithromycin |
Azatril |
Film coated tablet |
500 |
mg |
3 |
Actavis Group PTC ehf., Исландия |
300 |
mg |
- |
14.32 |
1.396 |
6.98 |
25% |
1.75 |
|
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
КЦРР-2515/06.03.2013; НСР-1570/01.11.2013 |
02.12.2013 |
|
|
Заличен |
1735 |
| J01FA10 |
Azithromycin |
AZAX |
Film coated tablet |
500 |
mg |
5 |
Нобел Фарма ЕООД, България |
300 |
mg |
- |
15.31 |
1.8372 |
15.31 |
25% |
3.83 |
J03 - до 18 години |
J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42 |
КЦРР-2964/20.03.2013; НСР-979/16.08.2013; НСР-7982/08.02.2016. |
02.03.2016 |
|
|
Заличен |
2042 |
| J01FA10 |
Azithromycin |
AZAX |
Film coated tablet |
500 |
mg |
3 |
Нобел Фарма ЕООД, България |
300 |
mg |
- |
11.75 |
1.8372 |
9.19 |
25% |
2.3 |
J03 - до 18 години |
J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42 |
№25/03.08.2009; КЦРР-1977/10.01.2013 г; НСР-979/16.08.2013.; НСР-7983/08.02.2016. |
02.03.2016 |
08.09.2012 |
|
Заличен |
2041 |
| J01FA10 |
Azithromycin |
AZIBIOT |
Film coated tablet |
500 |
mg |
3 |
KRKA, d.d., Словения |
300 |
mg |
- |
6.98 |
1.396 |
6.98 |
25% |
1.75 |
J03 - до 18 години |
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
№86/ 17.06.2010; НСР-1392/10.10.2013; НСР-4956/29.10.2014 |
16.11.2014 |
08.09.2012 |
|
Заличен |
2163 |
| J01FA10 |
Azithromycin |
Azitrox 250 |
Film coated tablet |
250 |
mg |
6 |
Zentiva k.s., Чешка република |
300 |
mg |
- |
10.73 |
1.83794 |
9.19 |
25% |
2.3 |
|
H66.0,J03,J15,J16,J40,J42,K25.7,K26 |
КЦРР-2727/20.03.2013 г.; НСР-942/12.08.2013 |
16.09.2013 |
08.09.2012 |
|
Заличен |
2365 |
| J01FA10 |
Azithromycin |
Azitrox 250 |
Film coated tablet |
250 |
mg |
3 |
Zentiva k.s., Чешка република |
300 |
mg |
- |
7.12 |
1.396 |
3.49 |
25% |
0.87 |
|
H66.0,J03,J15,J16,J40,J42,K25.7,K26 |
НСР-931/12.08.2013;НСР-1353/07.10.2013 |
02.11.2013 |
08.09.2012 |
|
Заличен |
2366 |
| J01FA10 |
Azithromycin |
Azitrox 500 |
Film coated tablet |
500 |
mg |
3 |
Zentiva k.s., Чешка република |
300 |
mg |
- |
10.14 |
1.83794 |
9.19 |
25% |
2.3 |
|
H66.0,J03,J15,J16,J40,J42,K25.7,K26 |
КЦРР-2728/20.03.2013 г.; НСР-942/12.08.2013 |
16.09.2013 |
08.09.2012 |
|
Заличен |
2276 |
| J01FA10 |
Azithromycin |
J01FA10 Azithromycin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01FA10 |
Azithromycin |
AZATRIL |
Powder for oral suspension |
200 mg/5 ml - 20 ml |
mg |
1 |
Актавис EАД, България |
300 |
mg |
- |
15.28 |
3.9855 |
10.63 |
25% |
2.66 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
НСР-1775/21.1.2013 |
16.12.2013 |
08.09.2012 |
|
Заличен |
214 |
| J01FA10 |
Azithromycin |
AZATRIL |
Powder for oral suspension |
100 mg/5 ml - 20 ml |
mg |
1 |
Актавис EАД, България |
300 |
mg |
- |
11.89 |
3.9855 |
5.31 |
25% |
1.33 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
НСР-1775/21.1.2013 |
16.12.2013 |
08.09.2012 |
|
Заличен |
213 |
| J01FA10 |
Azithromycin |
BINOZYT |
Powder for oral suspension |
200 mg/5 ml - 20 ml |
mg |
1 |
Sandoz d.d., Словения |
300 |
mg |
- |
12.58 |
3.9855 |
10.63 |
25% |
2.66 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
№ 151/ 14.03.2011; НСР-818/07.08-2013; НСР-2233/20.12.2013 |
16.01.2014 |
08.09.2012 |
|
Заличен |
1999 |
| J01FA10 |
Azithromycin |
BINOZYT |
Powder for oral suspension |
100 mg/5 ml - 20 ml |
mg |
1 |
Sandoz d.d., Словения |
300 |
mg |
- |
9.8 |
3.9855 |
5.31 |
25% |
1.33 |
за деца до 8 г. |
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
№ 151/ 14.03.2011; НСР-2234/20.12.2013 |
16.01.2014 |
08.09.2012 |
|
Заличен |
914 |
| J01FA10 |
Azithromycin |
Sumamed forte syrup |
Granules for oral suspension |
200 mg/ 5 ml - 15 ml |
mg |
1 |
Pliva Ljubljana d.o.o., Словения |
300 |
mg |
- |
11.41 |
3.9855 |
7.97 |
25% |
1.99 |
за деца до 8 г. |
H66.0,J03,J15,J16,J40,J42,K25.7,K26 |
№ 202/ 19.10.2011.;КЦРР-1248/15.08.2012 |
14.09.2012 |
08.09.2012 |
|
Заличен |
990 |
| J01FA10 |
Azithromycin |
Sumamed syrup |
Powder for oral suspension |
100 mg/ 5 ml - 20 ml |
mg |
1 |
Pliva Ljubljana d.o.o., Словения |
300 |
mg |
- |
11.59 |
3.9855 |
5.31 |
25% |
1.33 |
за деца до 8 г. |
H66.0,J03,J15,J16,J40,J42,K25.7,K26 |
КЦРР-784/15.06.2012 г.;КЦРР-1248/15.08.2012 |
14.09.2012 |
08.09.2012 |
|
Заличен |
1249 |
| J01FA10 |
Azithromycin |
ZMAX |
|
2 g/60 ml |
mg |
1 |
Pfizer Europe MA EEIG, Обединено Кралство |
300 |
mg |
- |
26.57 |
3.9855 |
26.57 |
25% |
6.64 |
|
H66.0,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.6,J15.7,J15.8,J16.0,J16.8,J40,J42,K25.7,K26.7 |
№25/03.08.2009.
№ 35/21.08.2009; НСР-3229/14.04.2014 |
16.05.2014 |
08.09.2012 |
|
Заличен |
657 |
| J01FF01 |
Clindamycin |
J01FF01 Clindamycin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| J01FF01 |
Clindamycin |
Clindamycin ABR 600 mg |
Capsule, hard |
600 |
mg |
30 |
Антибиотик Разград АД, България |
1200 |
mg |
- |
44.71 |
1.945 |
29.18 |
25% |
7.29 |
J03 - до 18 години |
A38,J03.0,J03.8,J03.9,J15.2,J15.3,J15.4,J15.7,J15.8,J16.0,J16.8,J40,J42 |
НСР-3936/30.06.2014; НСР-9240/05.05.2016 |
02.06.2016 |
|
|
Заличен |
2985 |